Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant

Vaccine

Volumn 24, Issue 49-50, 2006, Pages 7214-7225

  Hutcheon, Carolyn J ^a   Becker, Jessica O ^a   Russell, Brett A ^a   Bariola, Pauline A ^a   Peterson, Glenna J ^a   Stroop, Steven D ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Aluminum hydroxide; Antigenicity; Characterization; Elution

Indexed keywords

ALUMINUM HYDROXIDE; ANTIGEN; BOVINE SERUM ALBUMIN; DIMER; GUANIDINE; HYDROGEN; OXYGEN; PHOSPHORUS; REHYDRAGEL; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANTIGENICITY; ARTICLE; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); DRUG BINDING; DRUG FORMULATION; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT ABSORPTION; METHODOLOGY; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN STRUCTURE; STORAGE TEMPERATURE; STREPTOCOCCUS GROUP A;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANTIGENS, BACTERIAL; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT DYES; PROTEIN DENATURATION; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; SPECTROPHOTOMETRY, ULTRAVIOLET; STREPTOCOCCUS PYOGENES;

EID: 33846232744     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.043     Document Type: Article

References (25)

1. Vogel F.R., and Powell M.F. A compendium of vaccine adjuvants and excipients. Pharm Biotechnol 6 (1995) 141-228
2. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 32 (1998) 155-172
3. Ellis R.W. Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 19 17-19 (2001) 2681-2687
4. Seeber S.J., White J.L., and Hem S.L. Predicting the adsoption of proteins by aluminium-containing adjuvants. Vaccine 9 3 (1991) 201-203
5. Callahan P.M., Shorter A.L., and Hem S.L. The importance of surface charge in the optimization of antigen-adjuvant interactions. Pharm Res 8 7 (1991) 851-858
6. al-Shakhshir R.H., Regnier F.E., White J.L., and Hem S.L. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants. Vaccine 13 1 (1995) 41-44
7. Chang M.F., White J.L., Nail S.L., and Hem S.L. Role of electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjvant. PDA J Pharm Sci Technol 51 1 (1997) 25-29
8. Rinella J.V., Workman R.F., Hermondson M.A., White J.L., and Hem S.L. Elutability of proteins from aluminum-containing vaccine adjuvants by treatment with surfactants. J Colloid Interface Sci 197 (1998) 48-56
9. Rinella J.V., White J.L., and Hem S.L. Effects of pH on the elution of model antigens from aluminum-containing adjuvants. J Colloid Interface Sci 205 (1998) 161-165
10. Jendrek S., Little S.F., Hem S., Mitra G., and Giardina S. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21 21-22 (2003) 3011-3018
11. Levesque P.M., and de Alwis U. Mechanism of adsorption of three recombinant Streptococcus Pneumomoniae (Sp) vaccine antigens by aluminum adjuvant. Hum Vaccines 1 2 (2005) 70-73
12. al-Shakhshir R., Regnier F., White J.L., and Hem S.L. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants. Vaccine 12 5 (1994) 472-474
13. Iyer S., Robinett R.S.R., HogenEsch H., and Hem S.L. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine 22 (2004) 1475-1479
14. Weissburg R.P., et al. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm Res 12 10 (1995) 1439-1446
15. Heimlich J.M., Regnier F.E., White J.L., and Hem S.L. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins. Vaccine 17 22 (1999) 2873-2881
16. Diminsky D., Moav N., Gorecki M., and Barneholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18 1-2 (1999) 3-17
17. Capelle M.A.H., Brugger P., and Arvinte T. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity. Vaccine 23 14 (2005) 1686-1694
18. Ho M.M., Bogiano B., and Corbel M.J. Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines. Vaccine 19 7-8 (2000) 716-725
19. Jones L.S., Peek L.J., Power J., Marham A., Yazzie B., and Middaugh C.R. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem 280 14 (2005) 13406-13414
20. Shi Y., HogenEsch H., and Hem S.L. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines. Vaccine 20 1-2 (2001) 80-85
21. Bisno A.L., Rubin F.A., Cleary P.P., and Dale J.B. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles-report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis 41 8 (2005) 1150-1156
22. McNeil S.A., Halperin S.A., Langley J.M., Smith B., Warren A., Sharratt G.P., et al. Safety and immunogenicity of 26-valent group a strecptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41 8 (2005) 1114-1122
23. Dale J.B., Penfound T., Chiang E.Y., Long V., Shulman S.T., and Beall B. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol 12 7 (2005) 833-836
24. Hung H.-C., and Chang G.-G. Multiple unfolding intermediates of human placental alkaline phosphatase in equilibrium urea denaturation. Biophys J 81 (2001) 3456-3471
25. Carneiro F.A., Ferroaosa A.S., and Da Poin A.T. Low pH-induced conformational changes in vesicular stomatatis virus glycoprotein involve dramatic structure reorganization. J Biol Chem 276 1 (2001) 62-67